受强制性开放获取政策约束的文章 - Károly Palatka了解详情
无法在其他位置公开访问的文章：4 篇
Predictors of relapse in patients with ulcerative colitis in remission after one-year of infliximab therapy
K Farkas, PL Lakatos, F Nagy, Z Szepes, P Miheller, M Papp, K Palatka, ...
Scandinavian Journal of Gastroenterology 48 (12), 1394-1398, 2013
强制性开放获取政策： Hungarian Scientific Research Fund
Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort
A Bálint, M Rutka, Z Végh, Z Kürti, KB Gecse, J Banai, L Bene, ...
Expert opinion on drug safety 16 (8), 885-890, 2017
强制性开放获取政策： Magyar Tudományos Akadémia, National Office for Research, Development and …
Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis–results from multicenter observational cohort
A Bálint, M Rutka, M Kolar, M Bortlik, D Duricova, V Hruba, M Lukas, ...
Expert Opinion on Biological Therapy 18 (11), 1181-1187, 2018
强制性开放获取政策： National Office for Research, Development and Innovation, Hungary
Chronic inflammatory intestinal disorders in hidradenitis suppurativa
P Réka, EA Janka, L Soltész, IL Szabó, A Kapitány, Z Dajnoki, G Emri, ...
Dermatology 239 (4), 592-600, 2023
强制性开放获取政策： Magyar Tudományos Akadémia, National Office for Research, Development and …
可在其他位置公开访问的文章：19 篇
Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets
B Mesko, S Poliskal, A Szegedi, Z Szekanecz, K Palatka, M Papp, L Nagy
BMC medical genomics 3, 1-13, 2010
强制性开放获取政策： Howard Hughes Medical Institute
Efficacy of infliximab biosimilar CT-P13 induction therapy on mucosal healing in ulcerative colitis
K Farkas, M Rutka, PA Golovics, Z Végh, BD Lovász, T Nyári, KB Gecse, ...
Journal of Crohn's and Colitis 10 (11), 1273-1278, 2016
强制性开放获取政策： Magyar Tudományos Akadémia, Hungarian Scientific Research Fund
Long-term efficacy, safety, and immunogenicity of biosimilar infliximab after one year in a prospective nationwide cohort
L Gonczi, KB Gecse, Z Vegh, Z Kurti, M Rutka, K Farkas, PA Golovics, ...
Inflammatory bowel diseases 23 (11), 1908-1915, 2017
强制性开放获取政策： Hungarian Scientific Research Fund
Prediction of short-and medium-term efficacy of biosimilar infliximab therapy. Do trough levels and antidrug antibody levels or clinical and biochemical markers play the more …
L Gonczi, Z Vegh, PA Golovics, M Rutka, KB Gecse, R Bor, K Farkas, ...
Journal of Crohn's and Colitis 11 (6), 697-705, 2017
强制性开放获取政策： Hungarian Scientific Research Fund
Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease
F Rencz, PL Lakatos, L Gulácsi, V Brodszky, Z Kürti, S Lovas, J Banai, ...
Quality of Life Research 28, 141-152, 2019
强制性开放获取政策： Magyar Tudományos Akadémia
Efficacy and safety of adalimumab in ulcerative colitis refractory to conventional therapy in routine clinical practice
A Bálint, K Farkas, K Palatka, L Lakner, P Miheller, I Rácz, G Hegede, ...
Journal of Crohn's and Colitis 10 (1), 26-30, 2016
强制性开放获取政策： Magyar Tudományos Akadémia, Hungarian Scientific Research Fund
Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn's disease
B Mesko, S Poliska, A Váncsa, Z Szekanecz, K Palatka, Z Hollo, ...
Genome medicine 5, 1-10, 2013
强制性开放获取政策： Hungarian Scientific Research Fund
I-CARE, a European prospective cohort study assessing safety and effectiveness of biologics in inflammatory bowel disease
L Peyrin-Biroulet, JF Rahier, J Kirchgesner, V Abitbol, S Shaji, A Armuzzi, ...
Clinical Gastroenterology and Hepatology 21 (3), 771-788. e10, 2023
强制性开放获取政策： US National Institutes of Health
Anti-TNF-α antibody (infliximab) therapy supports the recovery of enos and VEGFR2 protein expression in endothelial cells
I Altorjay, Z Veréb, Z Serfőző, I Bacskai, R Bátori, F Erdődi, M Udvardy, ...
International Journal of Immunopathology and Pharmacology 24 (2), 323-335, 2011
强制性开放获取政策： Hungarian Scientific Research Fund
Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large …
M Papp, PL Lakatos, J Harsfalvi, G Farkas, K Palatka, M Udvardy, ...
Human Immunology 71 (4), 407-413, 2010
强制性开放获取政策： Hungarian Scientific Research Fund
Association of peroxisome proliferator-activated receptor gamma polymorphisms with inflammatory bowel disease in a Hungarian cohort
S Poliska, A Penyige, PL Lakatos, Hungarian IBD Study Group, M Papp, ...
Inflammatory bowel diseases 18 (3), 472-479, 2012
强制性开放获取政策： Howard Hughes Medical Institute, Hungarian Scientific Research Fund
Combination of IgG N‐glycomics and corresponding transcriptomics data to identify anti‐TNF‐α treatment responders in inflammatory diseases
C Váradi, Z Holló, S Póliska, L Nagy, Z Szekanecz, A Váncsa, K Palatka, ...
Electrophoresis 36 (11-12), 1330-1335, 2015
强制性开放获取政策： Magyar Tudományos Akadémia
Endoscopic sphincterotoMy for delayIng choLecystectomy in mild acute biliarY pancreatitis (EMILY study): protocol of a multicentre randomised clinical trial
LP Kucserik, K Márta, Á Vincze, G Lázár, L Czakó, Z Szentkereszty, ...
BMJ open 9 (7), e025551, 2019
强制性开放获取政策： Magyar Tudományos Akadémia, National Office for Research, Development and …
Patient and general population values for luminal and perianal fistulising Crohn’s disease health states
F Rencz, PFM Stalmeier, M Péntek, V Brodszky, G Ruzsa, L Gönczi, ...
The European Journal of Health Economics 20, 91-100, 2019
强制性开放获取政策： Magyar Tudományos Akadémia
Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease–A nationwide Hungarian cohort study
R Bor, A Fábián, M Matuz, Z Szepes, K Farkas, P Miheller, T Szamosi, ...
Expert opinion on biological therapy 20 (2), 205-213, 2020
强制性开放获取政策： National Office for Research, Development and Innovation, Hungary
What Is the Personal Experience of IBD Patients about Their Anti-TNF-Alpha Therapy?
Á Milassin, M Rutka, ÁA Csontos, P Miheller, K Palatka, M Szűcs, ...
Health 9 (07), 1007, 2017
强制性开放获取政策： Magyar Tudományos Akadémia
出版信息和资助信息由计算机程序自动确定